首页> 外文OA文献 >Operative complications and early mortality after induction therapy for lung cancer
【2h】

Operative complications and early mortality after induction therapy for lung cancer

机译:肺癌诱导治疗后的手术并发症和早期死亡率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract European Journal of Cardio-thoracic Surgery 31 (2007) 714—718 Operative complications and early mortality after induction therapy for lung cancer§ Federico Venuta *, Marco Anile, Daniele Diso, Mohsen Ibrahim, Tiziano De Giacomo, Matilde Rolla, Valeria Liparulo, Giorgio F. Coloni Cattedra di Chirurgia Toracica, Policlinico Umberto I, Universita` di Roma ‘‘La Sapienza’’, V.le del Policlinico, 00100 Rome, Italy Received 28 September 2006; received in revised form 20 December 2006; accepted 15 January 2007 Objective: Induction therapy for advanced lung cancer allows improvement of completeness of resection and survival. However, predictive risk factors for postoperative complications and early mortality remain controversial. We report our 14-year experience with this combined approach. Methods: One hundred and thirty-nine patients (100 males and 39 females) underwent induction therapy and surgery for stage IIIA and B lung cancer. The mean age was 58.4 7.7 years. We retrospectively collected demographic data, preoperative functional parameters, type of operation, associated disorders, staging, induction regimen (chemotherapy alone or associated with radiotherapy). Univariate and multivariate analyses were performed to identify predictors of postoperative complications and early mortality. Results: One hundred and nine patients received chemotherapy (mainly based on cisplatin and gemcitabine) and 30 received chemoradiotherapy (median dose 50 Gy). Complications developed in 49 patients (35%). The most frequent was persistent air leakage (23—30% of the lobectomies), followed by cardiac complications, respiratory failure, and infections. Five patients (3.5%) died in the postoperative period and four of them had received pneumonectomy (mortality for pneumonectomy: 12.5%). The statistical analysis demonstrated that only pneumonectomy was associated with an increased mortality risk with no differences between intra- and extrapericardial dissection or right and left pneumonectomy. Conclusions: Induction therapy seems to be associated with an increased incidence of air leakage; the risk of other complications is acceptable. Pneumonectomy is associated with an increased risk of mortality and should be performed in selected patients. # 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
机译:摘要欧洲心胸外科杂志31(2007)714–718肺癌诱导治疗后的手术并发症和早期死亡率§Federico Venuta *,Marco Anile,Daniele Diso,Mohsen Ibrahim,Tiziano De Giacomo,Matilde Rolla,Valeria Liparulo, Giorgio F. Coloni Cattedra di Chirurgia Toracica,Policlinico Umberto I,罗马大学“ La Sapienza”,V.le del Policlinico,00100意大利罗马,2006年9月28日收到; 2006年12月20日收到修订本; 2007年1月15日被接受目的:晚期肺癌的诱导疗法可改善切除的完整性和生存率。但是,术后并发症和早期死亡率的预测危险因素仍然存在争议。我们报告了这种组合方法14年的经验。方法:139例患者(男100例,女39例)接受了IIIA和B期肺癌的诱导治疗和手术。平均年龄是58.4 7.7岁。我们回顾性地收集了人口统计学数据,术前功能参数,手术类型,相关疾病,分期,诱导方案(单独进行化学疗法或与放射疗法相关)。进行单因素和多因素分析以鉴定术后并发症和早期死亡率的预测因素。结果:109例患者接受了化疗(主要基于顺铂和吉西他滨),30例接受了放化疗(中剂量为50 Gy)。 49例患者发生并发症(35%)。最常见的是持续的漏气(占肺叶切除术的23-30%),其次是心脏并发症,呼吸衰竭和感染。五例(3.5%)患者在术后死亡,其中四例接受了肺切除术(肺切除术死亡率:12.5%)。统计分析表明,只有肺切除术与死亡风险增加相关,而在心包内和心外剥离或左右肺切除术之间没有差异。结论:诱导治疗似乎与漏气的发生率增加有关。其他并发症的风险是可以接受的。肺切除术与死亡风险增加相关,应在部分患者中进行。 #2007年欧洲心胸外科协会。由Elsevier B.V.发布。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号